242 related articles for article (PubMed ID: 26561856)
21. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
[TBL] [Abstract][Full Text] [Related]
22. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.
Baktash Y; Madhav A; Coller KE; Randall G
Cell Host Microbe; 2018 Mar; 23(3):382-394.e5. PubMed ID: 29544098
[TBL] [Abstract][Full Text] [Related]
23. Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection.
Shirasago Y; Shimizu Y; Tanida I; Suzuki T; Suzuki R; Sugiyama K; Wakita T; Hanada K; Yagi K; Kondoh M; Fukasawa M
Biol Pharm Bull; 2016 May; 39(5):839-48. PubMed ID: 26887345
[TBL] [Abstract][Full Text] [Related]
24. Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.
Ciesek S; Westhaus S; Wicht M; Wappler I; Henschen S; Sarrazin C; Hamdi N; Abdelaziz AI; Strassburg CP; Wedemeyer H; Manns MP; Pietschmann T; von Hahn T
J Virol; 2011 Aug; 85(15):7613-21. PubMed ID: 21632765
[TBL] [Abstract][Full Text] [Related]
25. A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9.
Ulitzky L; Lafer MM; KuKuruga MA; Silberstein E; Cehan N; Taylor DR
PLoS One; 2016; 11(1):e0145212. PubMed ID: 26731262
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein.
Branche E; Conzelmann S; Parisot C; Bedert L; Lévy PL; Bartosch B; Clément S; Negro F
PLoS One; 2016; 11(1):e0146000. PubMed ID: 26731658
[TBL] [Abstract][Full Text] [Related]
27. Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner.
Fletcher NF; Sutaria R; Jo J; Barnes A; Blahova M; Meredith LW; Cosset FL; Curbishley SM; Adams DH; Bertoletti A; McKeating JA
Hepatology; 2014 Apr; 59(4):1320-30. PubMed ID: 24259385
[TBL] [Abstract][Full Text] [Related]
28. Species-specific regions of occludin required by hepatitis C virus for cell entry.
Michta ML; Hopcraft SE; Narbus CM; Kratovac Z; Israelow B; Sourisseau M; Evans MJ
J Virol; 2010 Nov; 84(22):11696-708. PubMed ID: 20844048
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
30. TNF-α Induced by Hepatitis C Virus via TLR7 and TLR8 in Hepatocytes Supports Interferon Signaling via an Autocrine Mechanism.
Lee J; Tian Y; Chan ST; Kim JY; Cho C; Ou JH
PLoS Pathog; 2015 May; 11(5):e1004937. PubMed ID: 26023919
[TBL] [Abstract][Full Text] [Related]
31. Occludin stalls HCV particle dynamics apart from hepatocyte tight junctions, promoting virion internalization.
Deffieu MS; Clément CMH; Dorobantu CM; Partiot E; Bare Y; Faklaris O; Rivière B; Ayala-Nunez NV; Baumert TF; Rondé P; Mély Y; Lucansky V; Gaudin R
Hepatology; 2022 Oct; 76(4):1164-1179. PubMed ID: 35388524
[TBL] [Abstract][Full Text] [Related]
32. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.
Benedicto I; Molina-Jiménez F; Bartosch B; Cosset FL; Lavillette D; Prieto J; Moreno-Otero R; Valenzuela-Fernández A; Aldabe R; López-Cabrera M; Majano PL
J Virol; 2009 Aug; 83(16):8012-20. PubMed ID: 19515778
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
[TBL] [Abstract][Full Text] [Related]
34. Tandem overexpression of five human factors renders murine hepatocytes susceptible to hepatitis C virus.
Lv L; Kang Q; Yu X; Gao B; Hu T; Ma P; Zhang Y; Yan F; Xiao J; Deng J; Zhou X; Xu J
Acta Virol; 2015 Mar; 59(1):20-6. PubMed ID: 25790047
[TBL] [Abstract][Full Text] [Related]
35. Studying HCV cell entry with HCV pseudoparticles (HCVpp).
Bartosch B; Cosset FL
Methods Mol Biol; 2009; 510():279-93. PubMed ID: 19009269
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C Virus Infection of Human Thyrocytes: Metabolic, Hormonal, and Immunological Implications.
Hammerstad SS; Blackard JT; Lombardi A; Owen RP; Concepcion E; Yi Z; Zhang W; Tomer Y
J Clin Endocrinol Metab; 2020 Apr; 105(4):1157-68. PubMed ID: 31784757
[TBL] [Abstract][Full Text] [Related]
37. Completion of the entire hepatitis C virus life cycle in genetically humanized mice.
Dorner M; Horwitz JA; Donovan BM; Labitt RN; Budell WC; Friling T; Vogt A; Catanese MT; Satoh T; Kawai T; Akira S; Law M; Rice CM; Ploss A
Nature; 2013 Sep; 501(7466):237-41. PubMed ID: 23903655
[TBL] [Abstract][Full Text] [Related]
38. Mouse hepatic cells support assembly of infectious hepatitis C virus particles.
Long G; Hiet MS; Windisch MP; Lee JY; Lohmann V; Bartenschlager R
Gastroenterology; 2011 Sep; 141(3):1057-66. PubMed ID: 21699799
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.
Fofana I; Krieger SE; Grunert F; Glauben S; Xiao F; Fafi-Kremer S; Soulier E; Royer C; Thumann C; Mee CJ; McKeating JA; Dragic T; Pessaux P; Stoll-Keller F; Schuster C; Thompson J; Baumert TF
Gastroenterology; 2010 Sep; 139(3):953-64, 964.e1-4. PubMed ID: 20685314
[TBL] [Abstract][Full Text] [Related]
40. High-throughput approaches to unravel hepatitis C virus-host interactions.
Colpitts CC; El-Saghire H; Pochet N; Schuster C; Baumert TF
Virus Res; 2016 Jun; 218():18-24. PubMed ID: 26410623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
